Literature DB >> 30385710

Glycine decarboxylase deficiency-induced motor dysfunction in zebrafish is rescued by counterbalancing glycine synaptic level.

Raphaëlle Riché1, Meijiang Liao1, Izabella A Pena2, Kit-Yi Leung3, Nathalie Lepage2, Nicolas DE Greene3, Kyriakie Sarafoglou4, Lisa A Schimmenti5,6,7, Pierre Drapeau1,8, Éric Samarut1,8.   

Abstract

Glycine encephalopathy (GE), or nonketotic hyperglycinemia (NKH), is a rare recessive genetic disease caused by defective glycine cleavage and characterized by increased accumulation of glycine in all tissues. Here, based on new case reports of GLDC loss-of-function mutations in GE patients, we aimed to generate a zebrafish model of severe GE in order to unravel the molecular mechanism of the disease. Using CRISPR/Cas9, we knocked out the gldc gene and showed that gldc-/- fish recapitulate GE on a molecular level and present a motor phenotype reminiscent of severe GE symptoms. The molecular characterization of gldc-/- mutants showed a broad metabolic disturbance affecting amino acids and neurotransmitters other than glycine, with lactic acidosis at stages preceding death. Although a transient imbalance was found in cell proliferation in the brain of gldc-/- zebrafish, the main brain networks were not affected, thus suggesting that GE pathogenicity is mainly due to metabolic defects. We confirmed that the gldc-/- hypotonic phenotype is due to NMDA and glycine receptor overactivation, and demonstrated that gldc-/- larvae depict exacerbated hyperglycinemia at these synapses. Remarkably, we were able to rescue the motor dysfunction of gldc-/- larvae by counterbalancing pharmacologically or genetically the level of glycine at the synapse.

Entities:  

Keywords:  Amino acid metabolism; Genetics; Neurological disorders; Neuroscience

Mesh:

Substances:

Year:  2018        PMID: 30385710      PMCID: PMC6238748          DOI: 10.1172/jci.insight.124642

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  42 in total

1.  Prediction of long-term outcome in glycine encephalopathy: a clinical survey.

Authors:  Julia B Hennermann; Jeanne-Marie Berger; Ulrike Grieben; Gunter Scharer; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2011-10-15       Impact factor: 4.982

2.  High-resolution in situ hybridization to whole-mount zebrafish embryos.

Authors:  Christine Thisse; Bernard Thisse
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

3.  Corrigendum: Swanson MA, Coughlin CR Jr, Scharer GH, et al: Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia. Ann Neurol 2015;78:606-618.

Authors:  Michael A Swanson; Curtis R Coughlin; Johan L K Van Hove
Journal:  Ann Neurol       Date:  2016-02-12       Impact factor: 10.422

4.  Stages of embryonic development of the zebrafish.

Authors:  C B Kimmel; W W Ballard; S R Kimmel; B Ullmann; T F Schilling
Journal:  Dev Dyn       Date:  1995-07       Impact factor: 3.780

5.  Mutations in SLC6A19, encoding B0AT1, cause Hartnup disorder.

Authors:  Robert Kleta; Elisa Romeo; Zorica Ristic; Toshihiro Ohura; Caroline Stuart; Mauricio Arcos-Burgos; Mital H Dave; Carsten A Wagner; Simone R M Camargo; Sumiko Inoue; Norio Matsuura; Amanda Helip-Wooley; Detlef Bockenhauer; Richard Warth; Isa Bernardini; Gepke Visser; Thomas Eggermann; Philip Lee; Arthit Chairoungdua; Promsuk Jutabha; Ellappan Babu; Sirinun Nilwarangkoon; Naohiko Anzai; Yoshikatsu Kanai; Francois Verrey; William A Gahl; Akio Koizumi
Journal:  Nat Genet       Date:  2004-08-01       Impact factor: 38.330

6.  The autism susceptibility gene met regulates zebrafish cerebellar development and facial motor neuron migration.

Authors:  Gina E Elsen; Louis Y Choi; Victoria E Prince; Robert K Ho
Journal:  Dev Biol       Date:  2009-09-02       Impact factor: 3.582

7.  Non-canonical mTOR-Independent Role of DEPDC5 in Regulating GABAergic Network Development.

Authors:  Amrutha Swaminathan; Rahma Hassan-Abdi; Solène Renault; Aleksandra Siekierska; Raphaëlle Riché; Meijiang Liao; Peter A M de Witte; Constantin Yanicostas; Nadia Soussi-Yanicostas; Pierre Drapeau; Éric Samarut
Journal:  Curr Biol       Date:  2018-05-31       Impact factor: 10.834

8.  Drug screening in Scn1a zebrafish mutant identifies clemizole as a potential Dravet syndrome treatment.

Authors:  Scott C Baraban; Matthew T Dinday; Gabriela A Hortopan
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

9.  Efficient generation of knock-in transgenic zebrafish carrying reporter/driver genes by CRISPR/Cas9-mediated genome engineering.

Authors:  Yukiko Kimura; Yu Hisano; Atsuo Kawahara; Shin-ichi Higashijima
Journal:  Sci Rep       Date:  2014-10-08       Impact factor: 4.379

10.  Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia.

Authors:  Michael A Swanson; Curtis R Coughlin; Gunter H Scharer; Heather J Szerlong; Kendra J Bjoraker; Elaine B Spector; Geralyn Creadon-Swindell; Vincent Mahieu; Gert Matthijs; Julia B Hennermann; Derek A Applegarth; Jennifer R Toone; Suhong Tong; Kristina Williams; Johan L K Van Hove
Journal:  Ann Neurol       Date:  2015-08-10       Impact factor: 10.422

View more
  2 in total

1.  Modeling Neuronal Diseases in Zebrafish in the Era of CRISPR.

Authors:  Angeles Edith Espino-Saldaña; Roberto Rodríguez-Ortiz; Elizabeth Pereida-Jaramillo; Ataúlfo Martínez-Torres
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

Review 2.  Zebrafish Is a Powerful Tool for Precision Medicine Approaches to Neurological Disorders.

Authors:  Katarzyna Ochenkowska; Aveeva Herold; Éric Samarut
Journal:  Front Mol Neurosci       Date:  2022-07-06       Impact factor: 6.261

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.